U.S. Markets close in 4 hrs 1 min

Top Ranked Growth Stocks to Buy for April 2nd

Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 2nd:

The Boeing Company (BA): This manufacturer of commercial jetliners and military aircraft etc, which carries a Zacks #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5% over the last 60 days.

The Boeing Company Price and Consensus

The Boeing Company Price and Consensus

The Boeing Company price-consensus-chart | The Boeing Company Quote

Boeing has a PEG ratio 1.50, compared with 1.80 for the industry. The company possesses a Growth Score of B.

The Boeing Company PEG Ratio (TTM)

The Boeing Company PEG Ratio (TTM)

The Boeing Company peg-ratio-ttm | The Boeing Company Quote

Charles River Laboratories International, Inc. (CRL): This early-stage contract research company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

Charles River Laboratories International, Inc. Price and Consensus

Charles River Laboratories International, Inc. Price and Consensus

Charles River Laboratories International, Inc. price-consensus-chart | Charles River Laboratories International, Inc. Quote

Charles River Laboratories International has a PEG ratio 1.87, compared with 3.20 for the industry. The company possesses a Growth Score of B.

Charles River Laboratories International, Inc. PEG Ratio (TTM)

Charles River Laboratories International, Inc. PEG Ratio (TTM)

Charles River Laboratories International, Inc. peg-ratio-ttm | Charles River Laboratories International, Inc. Quote

PRA Health Sciences, Inc. (PRAH): Thiscontract research organization, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.

PRA Health Sciences, Inc. Price and Consensus

PRA Health Sciences, Inc. Price and Consensus

PRA Health Sciences, Inc. price-consensus-chart | PRA Health Sciences, Inc. Quote

PRA Health Sciences has a PEG ratio 1.47, compared with 3.20 for the industry. The company possesses a Growth Score of A.

PRA Health Sciences, Inc. PEG Ratio (TTM)

PRA Health Sciences, Inc. PEG Ratio (TTM)

PRA Health Sciences, Inc. peg-ratio-ttm | PRA Health Sciences, Inc. Quote

WellCare Health Plans, Inc. (WCG): This government-sponsored managed care services provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

WellCare Health Plans, Inc. Price and Consensus

WellCare Health Plans, Inc. Price and Consensus

WellCare Health Plans, Inc. price-consensus-chart | WellCare Health Plans, Inc. Quote

WellCare Health Plans has a PEG ratio 1.27, compared with 1.53 for the industry. The company possesses a Growth Score of A.

WellCare Health Plans, Inc. PEG Ratio (TTM)

WellCare Health Plans, Inc. PEG Ratio (TTM)

WellCare Health Plans, Inc. peg-ratio-ttm | WellCare Health Plans, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
WellCare Health Plans, Inc. (WCG) : Free Stock Analysis Report
 
PRA Health Sciences, Inc. (PRAH) : Free Stock Analysis Report
 
Charles River Laboratories International, Inc. (CRL) : Free Stock Analysis Report
 
The Boeing Company (BA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research